- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 279/24 - Y étant un hétéro-atome
Détention brevets de la classe C07C 279/24
Brevets de cette classe: 42
Historique des publications depuis 10 ans
|
7
|
7
|
4
|
4
|
1
|
4
|
4
|
1
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Modernatx, Inc. | 1291 |
9 |
| Lantheus Medical Imaging, Inc. | 166 |
4 |
| Nippon Soda Co., Ltd. | 884 |
3 |
| Farmington Pharma Development | 7 |
2 |
| Trioptotec GmbH | 16 |
2 |
| The Regents of the University of California | 20745 |
1 |
| FUJIFILM Corporation | 30514 |
1 |
| Kaneka Corporation | 4703 |
1 |
| JPMorgan Chase Bank, National Association | 8956 |
1 |
| Cellix Bio Private Limited | 52 |
1 |
| Cortexyme, Inc | 11 |
1 |
| The Florida International University Board of Trustees | 672 |
1 |
| Fox Chase Chemical Diversity Center, Inc. | 15 |
1 |
| Immunomet Therapeutics Inc. | 31 |
1 |
| National University Corporation Tokyo University of Agriculture and Technology | 343 |
1 |
| Newsouth Innovations Pty Limited | 619 |
1 |
| Otsuka America Pharmaceutical, Inc. | 68 |
1 |
| Regents of the University of Minnesota | 2789 |
1 |
| Sekisui Medical Co., Ltd. | 695 |
1 |
| Shenyang Pharmaceutical University | 121 |
1 |
| Autres propriétaires | 7 |